Hopstem biotechnology will participate the 2024 BIO International Convention (referred to as "BIO 2024"), taking place in San Diego Convention Center, California, from June 3-6, 2024.
Dr. Jing Fan, the founder and CEO of Hopstem Biotechnology, will deliver a speech at this event, highlighting the company's latest clinical advancements and discussing trends in cutting-edge innovations and emerging industries. Additionally, we will engage in discussions with experts in CGT fields during the convention to explore the future of the biotechnology industry, foster collaboration, and seek potential partnership opportunities.
Mechanism study of hNPC01 neural progenitor cell grafting therapy in a rat ischemic stroke model was published in Nature Communications
Hopstem Won First Place at 2024 SAPA Investment Forum & online Road Show with Innovative iPSC Cell Therapy for Chronic Stroke
Hopstem Biotechnology at 2024 CASSS CGPT Symposium
Hopstem Biotechnology to Participate in the 2024 BIO International Convention in San Diego
R&D Center: Building 11,Heda Medicine Valley V, Qiantang Area,
Hangzhou, Zhejiang, China
Manufacturing Center: 3rd & 4th Floor, Building 10,Heda Medicine Valley lll,
Qiantang Area, Hangzhou, Zhejiang, China
U.S. Office: 103 Carnegie center, Suite 300, Princeton,
NJ 08540, USA
